| An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers E Przybytkowski, T Davis, A Hosny, J Eismann, UA Matulonis, GM Wulf, ... BMC cancer 20, 1-16, 2020 | 27 | 2020 |
| PTPRS regulates colorectal cancer RAS pathway activity by inactivating Erk and preventing its nuclear translocation TB Davis, M Yang, MJ Schell, H Wang, L Ma, WJ Pledger, TJ Yeatman Scientific reports 8 (1), 9296, 2018 | 27 | 2018 |
| X-ray excited luminescence and persistent luminescence of Sr2MgSi2O7: Eu2+, Dy3+ and their associations with synthesis conditions H Homayoni, S Sahi, L Ma, J Zhang, J Mohapatra, P Liu, AP Sotelo, ... Journal of Luminescence 198, 132-137, 2018 | 23 | 2018 |
| APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes R Thota, M Yang, L Pflieger, MJ Schell, M Rajan, TB Davis, H Wang, ... Cancers 13 (21), 5394, 2021 | 10 | 2021 |
| PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC TB Davis, M Yang, H Wang, C Lee, TJ Yeatman, WJ Pledger Oncotarget 10 (63), 6768, 2019 | 9 | 2019 |
| An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy M Yang, TB Davis, L Pflieger, MV Nebozhyn, A Loboda, H Wang, ... BMC cancer 22 (1), 256, 2022 | 6 | 2022 |
| Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer TB Davis, S Gupta, M Yang, L Pflieger, M Rajan, H Wang, R Thota, ... Cancers 14 (6), 1451, 2022 | 4 | 2022 |
| Matrix effect in atomic absorption determination of copper in fraction I protein: possible role of copper in light sensitive control of ribulose bisphosphate carboxylase activity LR Theriot, R Askins, C Chang, T Davis, S Gupta, J Talent, HF Tibbals, ... Texas journal of science 33 (2), 1981 | 4 | 1981 |
| A novel role of SRC in mediating bypass resistance to MEK inhibition in colorectal cancer stem cells M Yang, TBDB Davis, MV Nebozhyn, A Loboda, H Wang, MJ Schell, ... Cancer Research 81 (13_Supplement), 1083-1083, 2021 | 1 | 2021 |
| APC and TP53 as potential biomarkers for EGFR sensitivity in colorectal cancer. R Thota, M Yang, T Davis, MJ Schell, WJ Pledger, TJ Yeatman Journal of Clinical Oncology 38 (15_suppl), 4094-4094, 2020 | 1 | 2020 |
| Hotspot mutations of TP53 sensitize APC-mutated colorectal cancer cells to cetuximab in vitro M Yang, H Wang, TB Davis, L Pflieger, R Thota, WJ Pledger, TJ Yeatman Cancer Research 82 (12_Supplement), 5366-5366, 2022 | | 2022 |
| Molecular rationale for ERK and EGFR inhibition in colorectal cancer. TJ Yeatman, T Davis, M Yang, MJ Schell, H Wang, CMS Rocha Lima, ... Journal of Clinical Oncology 36 (4_suppl), 679-679, 2018 | | 2018 |
| Inactivation/loss of PTPRS promotes ERK activation that sensitizes colorectal cancer cells to ERK inhibitors TB Davis, M Yang, MJ Schell, H Wang, L Ma, WJ Pledger, TJ Yeatman Cancer Research 77 (13_Supplement), 4135-4135, 2017 | | 2017 |
